首页 > 最新文献

Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors最新文献

英文 中文
Pharmacology and therapeutics part A 药理学和治疗学
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90008-6
{"title":"Pharmacology and therapeutics part A","authors":"","doi":"10.1016/0362-5478(78)90008-6","DOIUrl":"https://doi.org/10.1016/0362-5478(78)90008-6","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90008-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137009189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitors of bacterial DNA-dependent RNA polymerase 细菌dna依赖性RNA聚合酶抑制剂
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90018-9
Joseph S. Krakow, S. Anand Kumar
{"title":"Inhibitors of bacterial DNA-dependent RNA polymerase","authors":"Joseph S. Krakow, S. Anand Kumar","doi":"10.1016/0362-5478(78)90018-9","DOIUrl":"10.1016/0362-5478(78)90018-9","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90018-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87388281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Defective interfering viruses and their influence on virus infections 缺陷干扰病毒及其对病毒感染的影响
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90014-1
Charlotte Jones, Ian Kennedy, John J. Holland
{"title":"Defective interfering viruses and their influence on virus infections","authors":"Charlotte Jones, Ian Kennedy, John J. Holland","doi":"10.1016/0362-5478(78)90014-1","DOIUrl":"10.1016/0362-5478(78)90014-1","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90014-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79527294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Interferon action and the cell surface 干扰素作用与细胞表面
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90025-6
R. Friedman
{"title":"Interferon action and the cell surface","authors":"R. Friedman","doi":"10.1016/0362-5478(78)90025-6","DOIUrl":"https://doi.org/10.1016/0362-5478(78)90025-6","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72781875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Cytochrome P-450—IV. Stability of cytochrome P-450 and conversion to cytochrome P-420: Isolation and properties of cytochrome P-420 细胞色素p - 450 - 4。细胞色素P-450的稳定性及向细胞色素P-420的转化:细胞色素P-420的分离及性质
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90010-4
Toshio Yamano, Yoshiyuki Ichikawa
{"title":"Cytochrome P-450—IV. Stability of cytochrome P-450 and conversion to cytochrome P-420: Isolation and properties of cytochrome P-420","authors":"Toshio Yamano, Yoshiyuki Ichikawa","doi":"10.1016/0362-5478(78)90010-4","DOIUrl":"10.1016/0362-5478(78)90010-4","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90010-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89203390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Hydroperoxides and superoxides in microsomal oxidations 微粒体氧化中的氢过氧化物和超氧化物
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90004-9
Peter J. O'Brien

The following scheme summarizes our present knowledge on the mechanism of the reactions carried out by cytochrome P450:

Xδ+ can be a protein radical or a porphyrin radical cation.

Donor can be: (i) reduced cytochrome b5 or NADPH:cytochrome c reductase; (ii) tetramethylphenylenediamine, dimethylphenylenediamine, diaminobenzidine; (iii) dimethylaniline or aminopyrine and resulting in N-dealkylation (Griffin, 1977); (iv) ROOH resulting in ROO. production and thereby increasing cytochrome P450 destruction, lipid peroxidation, singlet oxygen formation and oxidation of peroxidase donors; (v) unsaturated lipids resulting in lipid peroxidation and singlet oxygen formation; and (vi) various antioxidants.

S substrate can be amines, drugs, steroids, carcinogens, antioxidants R·CH2OH alcohols (from mechanism by Chance and Schonbaum, 1976). Hydroperoxides (e.g. ethyl hydroperoxide) that form alcohol substrates on reduction would be expected to be less effective in catalyzing hydroxylation reactions (Nordblom et al., 1976).

R·CHO Aldehyde product from alcohol oxidation ROOH Primary, secondary or tertiary hydroperoxides

The scheme explains the following three pathways involved in the formation of the oxenoid species:

  • 1.

    (1) Organic hydroperoxide catalyzed. This involves first the formation of an enzyme-peroxide complex (Reaction 1) followed by a fast rearrangement by an outer sphere electron transfer mechanism (Chance and Schonbaum, 1976). Some of this complex may be dissociated to the corresponding aldehyde and the original enzyme. The complex may also be hydrated to compound I, the active hydroxylating species, and release the alcohol. The hydroperoxide catalyzed alcohol oxidation (Rahimtula and O'Brien, 1976) can be explained by the reversal of these changes from compound I to the complex and dissociation of this complex (Reaction 4). The hydroperoxide catalyzed substrate hydroxylation involves the transfer of activated oxygen from compound I to the substrate (Reaction 5). It is also possible that alcohol oxidation proceeds by a hydroxylation mechanism, followed by the rearrangement of the ‘hydroxylated’ intermediate to an aldehyde. The hydroperoxide catalyzed oxidation of hydrogen or electron donors, unsaturated lipids or antioxidants involves the protein or porphyrin free radical of compound I and the ferryl iron of compound II. In competition with these donors, ROOH can also convert compound I to compound II (Chance, 1952; Reaction 6) and the resulting peroxy radicals can also oxidize these donors. In the absence of these donors, cytochrome P450 destruction readily occurs as a result of the peroxy radicals or protein or porphyrin radicals.

  • 2.

    (2) H2O2. The relatively high concentration of H2O2 required compared with that nee

下面的方案总结了我们目前对细胞色素P450进行的反应机制的了解:Xδ+可以是蛋白质自由基或卟啉自由基阳离子。供体可以是:(i)还原细胞色素b5或NADPH:细胞色素c还原酶;(ii)四甲基苯基二胺、二甲基苯基二胺、二氨基联苯胺;(iii)二甲苯胺或氨基吡啶并导致n -脱烷基(Griffin, 1977);(iv)导致ROO的ROOH。产生并因此增加细胞色素P450破坏、脂质过氧化、单线态氧形成和过氧化物酶供体的氧化;(v)导致脂质过氧化和单线态氧形成的不饱和脂质;(六)各种抗氧化剂。S底物可以是胺、药物、类固醇、致癌物、抗氧化剂R·CH2OH醇(from mechanism by Chance and Schonbaum, 1976)。在还原过程中形成醇底物的氢过氧化物(如氢过氧化乙酯)在催化羟基化反应中可能效果较差(Nordblom et al., 1976)。R·CHO醇氧化醛产物ROOH一级、二级或三级氢过氧化物该方案解释了类氧物质形成的以下三种途径:1.(1)有机氢过氧化物催化。这包括首先形成酶-过氧化物复合物(反应1),然后通过外球电子转移机制快速重排(Chance and Schonbaum, 1976)。其中一些复合体可以解离成相应的醛和原酶。该配合物也可水合成化合物I,即活性羟基化物质,并释放醇。氢过氧化物催化的醇氧化(Rahimtula和O'Brien, 1976)可以通过从化合物I到络合物的这些变化的逆转和该络合物的解离(反应4)来解释。氢过氧化物催化的底物羟基化涉及到活性氧从化合物I转移到底物(反应5)。醇氧化也可能通过羟基化机制进行。接着是“羟基化”中间体重排成醛。氢过氧化物催化的氢或电子供体、不饱和脂质或抗氧化剂的氧化涉及化合物I的蛋白质或卟啉自由基和化合物II的铁酰铁。在与这些供体的竞争中,ROOH还可以将化合物I转化为化合物II (Chance, 1952;反应6)和产生的过氧自由基也能氧化这些供体。在没有这些供体的情况下,细胞色素P450很容易被过氧自由基或蛋白质或卟啉自由基破坏。与烷基氢过氧化物相比,所需的H2O2浓度相对较高,并且碱性pH依赖性表明,氢过氧化物离子HO2 -形成可逆的酶过氧化物络合物(Nordblom et al., 1976;反应2).进一步的质子化和随后的水分子损失形成化合物I.3。(3)nadph还原酶催化。P450药物底物的结合极大地促进了P450的还原(Guengerich等,1975,1976)和亚铁蛋白的形成(Peterson等,1977)。磷脂增强了这种还原(Guengerich和Coon, 1975)。氧的结合非常迅速(Guengerich et al., 1976),质子化产生与H2O2形成的相同的叔过氧化物络合物。
{"title":"Hydroperoxides and superoxides in microsomal oxidations","authors":"Peter J. O'Brien","doi":"10.1016/0362-5478(78)90004-9","DOIUrl":"10.1016/0362-5478(78)90004-9","url":null,"abstract":"<div><p>The following scheme summarizes our present knowledge on the mechanism of the reactions carried out by cytochrome P450:</p><p>X<sup>δ+</sup> can be a protein radical or a porphyrin radical cation.</p><p>Donor can be: (i) reduced cytochrome <em>b</em><sub>5</sub> or NADPH:cytochrome <em>c</em> reductase; (ii) tetramethylphenylenediamine, dimethylphenylenediamine, diaminobenzidine; (iii) dimethylaniline or aminopyrine and resulting in N-dealkylation (Griffin, 1977); (iv) ROOH resulting in ROO<sup>.</sup> production and thereby increasing cytochrome P450 destruction, lipid peroxidation, singlet oxygen formation and oxidation of peroxidase donors; (v) unsaturated lipids resulting in lipid peroxidation and singlet oxygen formation; and (vi) various antioxidants.</p><p>S substrate can be amines, drugs, steroids, carcinogens, antioxidants R·CH<sub>2</sub>OH alcohols (from mechanism by Chance and Schonbaum, 1976). Hydroperoxides (e.g. ethyl hydroperoxide) that form alcohol substrates on reduction would be expected to be less effective in catalyzing hydroxylation reactions (Nordblom <em>et al.</em>, 1976).</p><p>R·CHO Aldehyde product from alcohol oxidation ROOH Primary, secondary or tertiary hydroperoxides</p><p>The scheme explains the following three pathways involved in the formation of the oxenoid species: </p><ul><li><span>1.</span><span><p>(1) <em>Organic hydroperoxide catalyzed</em>. This involves first the formation of an enzyme-peroxide complex (Reaction 1) followed by a fast rearrangement by an outer sphere electron transfer mechanism (Chance and Schonbaum, 1976). Some of this complex may be dissociated to the corresponding aldehyde and the original enzyme. The complex may also be hydrated to compound I, the active hydroxylating species, and release the alcohol. The hydroperoxide catalyzed alcohol oxidation (Rahimtula and O'Brien, 1976) can be explained by the reversal of these changes from compound I to the complex and dissociation of this complex (Reaction 4). The hydroperoxide catalyzed substrate hydroxylation involves the transfer of activated oxygen from compound I to the substrate (Reaction 5). It is also possible that alcohol oxidation proceeds by a hydroxylation mechanism, followed by the rearrangement of the ‘hydroxylated’ intermediate to an aldehyde. The hydroperoxide catalyzed oxidation of hydrogen or electron donors, unsaturated lipids or antioxidants involves the protein or porphyrin free radical of compound I and the ferryl iron of compound II. In competition with these donors, ROOH can also convert compound I to compound II (Chance, 1952; Reaction 6) and the resulting peroxy radicals can also oxidize these donors. In the absence of these donors, cytochrome P450 destruction readily occurs as a result of the peroxy radicals or protein or porphyrin radicals.</p></span></li><li><span>2.</span><span><p>(2) H<sub>2</sub>O<sub>2</sub>. The relatively high concentration of H<sub>2</sub>O<sub>2</sub> required compared with that nee","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90004-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84010415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 37
DNA and RNA polymerases of mammalian cells and tumor viruses 哺乳动物细胞和肿瘤病毒的DNA和RNA聚合酶
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90002-5
H.S. Allaudeen
{"title":"DNA and RNA polymerases of mammalian cells and tumor viruses","authors":"H.S. Allaudeen","doi":"10.1016/0362-5478(78)90002-5","DOIUrl":"10.1016/0362-5478(78)90002-5","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90002-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90714316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Reconstituted mammalian mixed-function oxidases: Requirements, specificities and other properties 重组哺乳动物混合功能氧化酶:要求、特性和其他性质
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90021-9
Anthony Y.H. Lu, Susan B. West
{"title":"Reconstituted mammalian mixed-function oxidases: Requirements, specificities and other properties","authors":"Anthony Y.H. Lu,&nbsp;Susan B. West","doi":"10.1016/0362-5478(78)90021-9","DOIUrl":"10.1016/0362-5478(78)90021-9","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90021-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"119511180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 65
Modulation of immunity by levamisole 左旋咪唑对免疫的调节
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90024-4
Gerard Renoux
{"title":"Modulation of immunity by levamisole","authors":"Gerard Renoux","doi":"10.1016/0362-5478(78)90024-4","DOIUrl":"10.1016/0362-5478(78)90024-4","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0362-5478(78)90024-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90439713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Reconstituted mammalian mixed-function oxidases: Requirements, specificities and other properties 重组哺乳动物混合功能氧化酶:要求、特性和其他性质
Pub Date : 1978-01-01 DOI: 10.1016/0362-5478(78)90021-9
A. Y. Lu, S. B. West
{"title":"Reconstituted mammalian mixed-function oxidases: Requirements, specificities and other properties","authors":"A. Y. Lu, S. B. West","doi":"10.1016/0362-5478(78)90021-9","DOIUrl":"https://doi.org/10.1016/0362-5478(78)90021-9","url":null,"abstract":"","PeriodicalId":101016,"journal":{"name":"Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86843788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 65
期刊
Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1